tirzepatide injection new market Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major Tirzepatide in Seattle at Well

Alternatives: Are there better-established options for what I am trying to achieve

GERD (acid reflux): Also more common with Wegovy , 11% versus 6% with Zepbound

It also is not advised for people who are pregnant or breastfeeding, or for children under 18 years of age

The mechanism is under investigation but likely related to glucagon receptor activation

Yes there are no contraindications to resistance training on GLP-1 medications

Secondary outcomes included the proportion of patients who achieved 5% or more, 10% or more, 15% or more and 20% or more weight loss at 3 and 6 months and the percentage of weight loss for those with or without type 2 diabetes